Introduction

Over the past two decades, endovascular therapy (EVT) has emerged as an increasingly important treatment option for intracranial aneurysms (IAs) with EVT being a less-invasive procedure and carrying fewer short-term complications compared to open microsurgery [22, 30]. The ability to refer complex cases to EVT has improved overall outcomes [8], particularly among patients who are older and those who have medical comorbidities [37]. However, as fewer cases are treated with open microsurgery, microsurgical skills and surgical confidence may erode over time, and this may have the unintended adverse consequences of increasing complication rates and worsening outcomes associated with microsurgery.

Nevertheless, there remain select IAs that may be more safely and effectively treated with open microsurgery which, at times, carries the best opportunity for a good long-term outcome. When deciding whether or not to recommend treatment for an unruptured IA and whether conservative management, open microsurgery, or EVT is most appropriate, physicians must rely on a detailed understanding of the risks and potential complications associated with each of these options. We have previously reported decision-making algorithms and surgical outcomes in selected subgroups of patients with unruptured IAs [34,35,36,37]. In this report, we describe the overall complication rates in a large series of unruptured IAs treated with microsurgery at our center over a 23-year period.

Methods

Patient review

Between July 1997 and June 2019, 1750 patients with 1923 unruptured IAs were entered into a prospectively collected database of patients undergoing microsurgery for an unruptured IA. We retrospectively reviewed the operative reports, imaging studies, and follow-up clinic notes of all patients who suffered a postoperative complication in this series noting both permanently disabling and temporary or non-disabling complications.

Management strategy

Our algorithm for the management of patients with unruptured IAs has been described previously [32, 34,35,36,37]. All patients were evaluated by a multidisciplinary team including a neurovascular surgeon and an interventional neuroradiologist who reviewed all imaging studies and then recommended either conservative management, open microsurgery, or EVT. In general, we have recommended observation with follow-up imaging to older patients, those with smaller aneurysms, and those in poor medical condition. Treatment was generally recommended for younger patients with larger lesions, those patients with aneurysms that show interval enlargement on serial imaging studies, and those with a strong family history of IA or personal history of subarachnoid hemorrhage (SAH) from another aneurysm. Symptomatic aneurysms (those with perianeurysmal edema resulting in neurological dysfunction or seizure, or causing third nerve palsy) were also generally offered treatment.

When treatment was recommended, patients with narrow-necked or calcified IAs, patients over 70 years of age, and those with significant medical comorbidities were generally offered EVT, while surgical clipping was recommended to patients with very small IAs (≤ 3 mm) that were nevertheless deemed appropriate for treatment, patients with very wide necked or fusiform lesions, or when treatment with EVT was not felt to be feasible or was attempted and proved unsuccessful. When choosing between open microsurgery and EVT, we recommend the option that offers the lowest major complication rate while attempting to provide a reasonable chance for a long-term durable result.

Surgical procedures

Details of our specific surgical techniques and bypass procedures have been described previously [32,33,34,35,36,37]. All procedures were performed under general endotracheal anesthesia using barbiturate anesthesia and mild hypothermia (34 °C). Patients received mannitol (1 g/kg), decadron (4–10 mg intravenously), and a loading dose of either fosphenytoin or levetiracetam. Intravenous antibiotics were administered preoperatively and continued for 24 h postoperatively. Patients were secured in a radiolucent head frame for surgery. A standard pterional approach was used for most anterior circulation lesions. Additional skull base dissection, including orbitocranial, and orbitozygomatic approaches, were used to obtain optimal visualization of the aneurysm when necessary. Distal anterior cerebral artery (ACA) lesions were treated via parasagittal craniotomy. Basilar artery (BA) lesions were generally treated via a subtemporal approach or a combined half-and-half approach with orbitozygomatic osteotomy [32]. Posterior inferior cerebellar artery (PICA) aneurysms generally underwent a far lateral suboccipital craniotomy. An interhemispheric approach was used for anterior communicating artery (ACOMMA) aneurysms when it was anticipated that the local vascular anatomy would have hidden the aneurysm neck from view when approaching from either side.

An intentional subtotal aneurysm clipping was performed when attempted complete occlusion resulted in significant narrowing of the parent artery or perforator compromise or when calcification or atheroma precluded safe clip placement at the aneurysm neck. In these cases, the area left untreated was subsequently wrapped with muslin-type gauze, cotton, or Gore-Tex.

The intradural portion of all surgeries, including opening of the Sylvian fissure and dissection and clipping of the aneurysm, was performed under microsurgical magnification. No neuromonitoring was used except when parent artery occlusion (PAO) was employed. Intraoperative digital subtraction angiography (DSA) was used in all cases to evaluate IA occlusion and to exclude the presence of vascular compromise. Indocyanine green (ICG) video angiography was also used in all cases after 2010 to evaluate perforator patency. All patients were monitored overnight in a neurointensive care unit, and systolic blood pressure was kept below 140 mm Hg. Patients were mobilized the night of surgery as tolerated. Postoperative CT and MR imaging were performed only when patients demonstrated a new deficit or severe headache after surgery.

For patients undergoing revascularization with PAO, intraoperative angiography was used to confirm bypass patency. Once revascularization was complete, the IA was treated surgically by sacrificing the parent artery with proximal occlusion when possible; otherwise, a distal occlusion was performed when anatomy precluded access to the parent artery proximal to the aneurysm.

Post-operative follow-up and complications

Peri-procedural and immediate post-operative complications were recorded to determine the incidence of non-disabling complications versus disabling and/or fatal complications following microsurgical clipping of unruptured IAs. We evaluated patients daily during their initial hospitalization, at the time of discharge, again 1–2 weeks post-procedure at the time of suture removal, and then at a 4–6-week follow-up visit. Patients who developed a new deficit or any complication that was noted during any of these examinations were followed beyond this period. Patients who traveled from out of state for treatment were seen in follow-up by their local physician, and telephone follow-up was performed by our nursing staff. Postoperative infection was recorded in patients who required hospital readmission for intravenous antibiotic therapy or surgical revision; this study did not account for cases in which the patient’s primary care physician may have prescribed oral antibiotics for a minor or superficial wound infection.

Because neurosurgeons have been criticized for inadequately assessing postoperative cognitive and quality-of-life concerns in patients undergoing craniotomy, we have used Short-Form patient questionnaires SF-12 and/or SF-36 for all patients at last follow-up. Patients were asked to categorize their abilities to return to work or previous lifestyle as requiring no modification, minor modification, major modification, or as unable to return.

For imaging follow-up, patients less than age 60 with complete intraoperative aneurysm occlusion were recommended to undergo 5-year follow-up imaging with magnetic resonance angiography (MRA) or computed tomography angiography (CTA). Patients older than age 60 with complete intraoperative occlusion did not have scheduled follow-up imaging. Patients with > 90% but < 100% aneurysm occlusion were recommended follow-up MRA or CTA at 1 and 5 years after surgery. Patients with < 90% occlusion underwent DSA at 1 year, with additional follow-up determined by our team based on the results of that study. When examining occlusion as an outcome of this study, rates of > 95% occlusion (complete or near-complete occlusion) and 90–95% occlusion are reported.

Results

Patient characteristics and aneurysm morphology

Patient demographics and aneurysm characteristics are presented in Tables 1 and 2. Collectively, there were 1923 unruptured IAs treated in 1750 patients (mean age 44 [range: 6–84], 62.0% [1085/1750] female). The most common comorbidities included smoking in 23.0% (403/1750) of patients, hypertension in 22.0% (385/1750), hyperlipidemia in 19.0% (333/1750), and diabetes mellitus in 11.0% (193/1750). A total of 5.2% (91/1750) of patients had experienced subarachnoid hemorrhage (SAH) from a previously treated IA, 12.0% (210/1750) had a family history of IA, and 4.3% (82/1923) of treated aneurysms had been previously coiled but suffered repeated coil compaction. In 22 additional cases, we attempted coiling but were unsuccessful due to local aneurysm anatomy or vascular morphology/tortuosity of the carotid or vertebral artery; these patients were then treated surgically.

Table 1 Patient demographics and characteristics of 1923 unruptured aneurysms
Table 2 Aneurysm locations and size distribution

Microsurgical clipping was performed in 93.0% (1789/1923) of cases, while 1.2% (22/1923) of aneurysms were treated with wrapping alone, and 5.3% (102/1923) were treated with bypass and PAO. In 7.1% (137/1923) of cases, repair of another aneurysm was performed simultaneously, and 1.5% (26/1750) patients underwent multiple craniotomies to treat their aneurysms. Intraoperative rupture occurred in 0.4% (7/1923) of treated aneurysms.

Aneurysm sizes and locations are detailed in Table 2. The majority (84.9%, 1632/1923) of aneurysms were small (< 10 mm), 11.1% (213/1923) were large (10–< 25 mm), and 4.1% (78/1923) were giant (≥ 25 mm). Aneurysm locations included the middle cerebral artery (MCA) in 44.2% (850/1923), the internal carotid artery (ICA) in 29.1% (560/1923), the ACA in 21.0% (404/1923), mostly at the ACOMMA (15.6% [300/1923]), and the vertebrobasilar system in 5.7% (109/1923).

Postoperative follow-up

No aneurysms bled during the follow-up period, which ranged from 12 months to 21 years, mean 8.8 years. Two small ACOMMA aneurysms and one small basilar apex aneurysm were stable based on imaging at 1 year, but showed minimal growth (< 2 mm) at 5 years and continue to be followed 6, 9, and 11 years post-surgery. One fusiform MCA aneurysm that had been treated with wrapping alone showed significant enlargement and was subsequently treated with endovascular stenting without incident. No patient with intraoperative rupture suffered a complication, and all had good outcomes at the time of last follow-up visit.

Occlusion rates, complications, and mortality

Complete or near-complete (> 95%) aneurysm occlusion was achieved in 92.9% (1786/1923) aneurysms; 5.4% (104/1923) had 90–95% occlusion, and 1.2% (23/1923) aneurysms were wrapped only due to atheroma or calcification involving the aneurysm wall/neck.

Surgical complications resulting in permanent deficit or death are presented in Table 3. Overall treatment-related complications occurred in 7.4% (129/1750) of patients, among whom 0.4% (7/1750) experienced a permanent disability and 0.3% (5/1750) died. Serious surgical complications resulting in new permanent disability included one case of delayed saphenous vein graft thrombosis in a patient with a giant MCA aneurysm that lead to severe permanent disability requiring assistance with activities of daily living; perforator artery injury in two patients with an MCA aneurysm resulting in permanent hemiparesis (one case was severe, and one was mild), one subdural hemorrhage in a patient with a small ACOMMA aneurysm that lead to a prolonged dependent state, one case of subfrontal contusion in a patient with a small paraclinoid aneurysm leading to persistent mild dysphasia, one case of severe visual impairment in a patient with a giant paraclinoid aneurysm, and one case of third nerve palsy in a patient with a large basilar artery aneurysm leading to permanent ptosis.

Table 3 Serious surgical complications resulting in new permanent disability or death

Five patients (0.3% [5/1750]) died as a result of major complications in the post-operative period. One patient with a small ACOMMA aneurysm experienced a disseminated intravascular coagulation on post-operative day 1, resulting in multi-system organ failure; the patient died despite treatment with anticoagulation and supportive care. Another patient with a small ACOMMA aneurysm experienced severe myocardial infarction, and died despite treatment with an intra-aortic balloon pump. An older woman with a giant cavernous ICA aneurysm died after a suffering large infarct of the MCA following ICA sacrifice. This patient passed her balloon test occlusion both clinically and in terms of single-photon emission computed tomography (SPECT) analysis. We believe she suffered a large embolic MCA infarction despite low-dose anticoagulation and antiplatelet therapy. One patient with a small carotid ophthalmic aneurysm died suddenly at home on post-operative day 21 due to a pulmonary embolism that was subsequently identified at autopsy. One patient with a giant PICA aneurysm died after experiencing post-operative pneumonia and meningitis leading to sepsis and multisystem organ failure despite prolonged antibiotic therapy and lumbar drainage.

Surgical complications not resulting in permanent deficit or death are presented in Table 4. The most frequent non-disabling complication was deep vein thrombosis (DVT) with or without pulmonary embolism (PE) occurring in 2.2% (38/1750) of patients. A total of 1.8% (31/1750) of patients were displeased with the cosmetic result of the surgery, and five of these elected to undergo delayed cosmetic reconstruction by a plastic surgeon. Chronic subdural hematoma occurred in 1.0% (17/1750) of patients; four underwent delayed surgical evacuation 5 weeks to 6 months after their initial surgery. Major wound infections occurred in 12 cases, 5 of which required reoperation, with immediate replacement of the bone flap with a titanium mesh cranioplasty in four and delayed cranioplasty in one. The remainder were managed with antibiotic therapy alone. Postoperative seizure occurred in 0.5% (8/1750) patients; one had a prior history of epilepsy, and no other patients required permanent anticonvulsant therapy thereafter. Other less frequently occurring (< 1.0%) non-disabling complications included transient third nerve palsy, asymptomatic myocardial infarction, ipsilateral vocal cord paralysis and/or transient dysphagia (following PICA aneurysm repair), complete olfactory loss, transient hemiparesis, epidural hematoma, and venous ischemia in one patient undergoing an interhemispheric approach for a distal ACA aneurysm. This last patient required prolonged intensive care unit (ICU) monitoring for cerebral edema but ultimately had an excellent outcome.

Table 4 Surgical complications not resulting in permanent deficit

Overall, the vast majority of patients (95.9% [1678/1750]) were able to return to their previous lifestyles with no modifications (Table 5). A smaller percentage reported the need for minor (3.3% [58/1750]) or major (0.2% [5/1750]) modifications to their lifestyle, and 0.5% (9/1750) were unable to return to work or previous lifestyle due to death or poor outcome. Three patients with permanent disabilities were able to return to work or previous lifestyle with modifications (Patients 7, 10, and 12 in Table 3). Among the patients requiring modifications, 49 who would have been judged to have good clinical outcomes based on traditional reporting measures nevertheless felt their quality of life was worse postoperatively on a subjective basis, due to complaints including anxiety regarding potential aneurysm recurrence, headaches, intermittent facial swelling, anosmia, and attention difficulties interfering with job performance. A total of 25/72 (34.7%) of these patients requiring modifications or unable to return to previous lifestyle carried psychiatric diagnoses before surgery including major depression and/or anxiety disorder. All of these patients were able to return to work or previous lifestyle with minor or major modification with the exception of the patient with anosmia who chose not to return to work.

Table 5 Evaluation of quality-of-life/functional outcomes

Discussion

The optimal management of unruptured IAs requires meticulous selection of the best treatment regimen for each individual patient based on a thorough appreciation of the risks and potential complications associated with conservative management, open microsurgery, and EVT. Such a detailed understanding of each treatment option is central to the decision-making process because the natural history of many unruptured IAs is benign and because there may be selected subsets of IAs that are best treated with EVT while others, due to location, size, morphology, or patient characteristics, will be better managed with open microsurgery. Our series demonstrates that microsurgical treatment provides low morbidity and mortality rates when a multidisciplinary team approach is used to determine the optimal treatment pathway at a high-volume center. Although the diminishing incidence of serious complications over time may be related to increased surgical experience by the senior author, we suggest that the improvement of EVT techniques and the ability to refer cases for EVT when a high complication rate with open microsurgery was expected have played a major role in improving our complication rates.

Microsurgery and endovascular treatment

The rapid evolution of EVT including the introductions of flow diversion and intrasaccular flow disruption techniques has resulted in proportionally fewer aneurysms being treated via microsurgical clipping [14, 44]. We suggest that increasing technical experience over time as well as the ability to refer complicated cases to EVT as a treatment option have contributed to an overall decrease in our surgical complication rates. For example, following the introduction of stenting as a useful option for the management of wide-necked aneurysms, we have only rarely performed microsurgery for larger basilar apex aneurysms, effectively eliminating surgical complications in this challenging group of aneurysms. Paradoxically, however, this trend has likely resulted in an erosion of microsurgical skills which may increase complication rates with open microsurgery performed by less experienced surgeons. This phenomenon has led some to predict the appropriateness of replacing open microsurgery with EVT in almost all IA cases. In contrast, at our center, we have always viewed EVT and open surgery as complementary rather than competitive and have recommended whichever option we believe will result in good aneurysm obliteration while carrying the lowest complication rates, offering the patient the best chance for a good long-term outcome. Based on this experience, we suggest that such a combined team approach can offer better results than an imbalanced approach where EVT or surgery dominate the treatment decision.

Microsurgery continues to be safe and effective for many patients [34], especially younger individuals [25, 37], those with smaller lesions, wide-necked aneurysms [1, 2, 37, 40], unruptured MCA aneurysms [9, 13, 16, 35], and aneurysms with complex perforator involvement [20]. As a consequence, we typically offer open microsurgery to patients with MCA aneurysms which tend to have a wide neck often incorporating the M2 branches and which therefore carry lower treatment-related morbidity with open surgery in our experience. In contrast, we recommend open surgery for VBA aneurysms only when EVT is felt to be impossible or to carry a significantly higher risk than open microsurgery. Therefore, the vast majority of VBA aneurysms, and particularly VB junction aneurysms and those occurring at the basilar apex, are currently treated using EVT in our practice.

Importantly, a number of reviews have found similar overall complication rates between microsurgical and EVT techniques in patients with unruptured IAs [10, 19, 41, 43]. A recent meta-analysis by Kang et al. reviewed data from 129,317 patients with unruptured IAs and showed a significantly lower rate of procedural complications with coiling vs. surgical clipping (4.6% vs. 7.0%, P < 0.001) [22], but notably showed that EVT had a lower rate of complete occlusion at short-term (OR 0.179, 95% CI 0.064–0.499, P = 0.001) and 1-year follow-up (OR 0.307, 95% CI 0.146–0.646, P = 0.002) [22]. Higher rates of complete occlusion and lower rates of recurrence in patients treated surgically have been corroborated in other studies [15, 16, 19, 26, 31, 41, 42, 44, 45]. However, several reports have found higher morbidity and mortality rates in patients treated microsurgically, including a study by Brinjikji et al. that analyzed NIS hospital discharge data to evaluate the outcomes of 64,043 patients with unruptured IAs (29,918 treated with surgery and 34,125 treated with EVT) [8]. Compared to EVT, the authors reported higher rates of mortality (1.2% vs. 0.6%, P < 0.0001), surgical complications (3.3% vs. 1.6%, P < 0.0001), neurological complications (7.8% vs. 2.3%, P < 0.0001), and overall complications including discharge to long-term facility (14.0% vs. 4.9%, P < 0.0001) among patients treated with clipping [8].

Though a number of large studies have found relatively high complication rates associated with open microsurgery for IAs, with mortality rates as high as 2.66% [4, 8, 27], such large national sample studies include patients managed with open surgery at low volume centers which may inappropriately inflate complication and death rates. By centralizing the management of IAs at higher volume multidisciplinary centers that offer a team approach, patients that would be best treated with EVT can be removed from the equation, and better outcomes can be offered for those complex aneurysms still requiring open surgery. It should come as no surprise that when looking at an unselected series of IAs at all locations, EVT will offer lower short-term complication rates than open microsurgery. But by using a careful selection process, teams can optimize surgical results, offering better outcomes with lower complication and mortality rates. In addition, microsurgical techniques avoid particular device-related complications such as coil stretching or migration [38, 43], and numerous studies have reported that microsurgery confers a lower risk of thromboembolic complications [7, 22, 24, 38, 43], and provides better long-term occlusion and reduced recurrence/retreatment rates in patients with unruptured IAs [7, 15, 42].

Multiple factors likely contributed to the favorable outcomes achieved in this series. We have alluded to increasing experience over time at a high-volume center with the experience being concentrated in the hands of a single surgeon. Equally important in our opinion was the integrated team approach, creating a collaborative rather than competitive environment in which each patient was discussed openly, and the treatment option felt to carry the best long-term result balanced with the lowest complication rate was recommended to the patient. As endovascular techniques have improved, we have increasingly relied on EVT, allowing us to treat the most dangerous surgical aneurysms using less risky means. Finally, a standardized approach incorporating repeated application of the same principles to pre-, intra-, and post-operative care have likely improved our outcomes as well. We believe that such a standardized approach allows everyone who touches the patient to develop a high level of comfort and expertise with the issues unique to IA patients, and we consider this important in optimizing outcomes.

Predictors of complications

A major meta-analysis of 54 studies including data on 108,263 unruptured IAs treated surgically found an overall pooled postoperative complication rate of 8.34% [3]. Ischemic complication rates in these studies range between 2.5 and 10% [3, 23, 44], ischemic stroke rates range from 4.3 to 8.16% [4, 6, 23], hemorrhagic complications rates from 2.38 to 5% [3, 4, 44], cardiac complications rates from 0.15 to 3.18% [4, 8, 23], and PE rates from 0.91 to 2.11% [4, 23]. Specific preoperative comorbidities associated with poor outcome and readmission include older age, obesity (class II or III), hypertension, congestive heart failure, coagulopathy, smoking, alcohol/drug use, anemia, preoperative hyponatremia, aneurysm size, and posterior circulation unruptured IA [1, 3, 11, 12, 17, 23, 27, 29]. If surgical morbidity is anticipated to be high due to these factors, then EVT should be considered or conservative management without intervention may be most appropriate.

The current study found lower rates of morbidity and mortality than were found in other large studies for EVT or microsurgery, indicating that the range of patient outcomes in treating IAs may be influenced by factors other than the chosen treatment modality. Given the invasive nature and technical challenges associated with microsurgical treatment, outcomes are also heavily dependent on a given center’s microsurgical and interventional experience, institutional support, and the implementation of effective treatment algorithms based on careful risk stratification of patients [5, 18, 21, 28, 39]. Morbidity and mortality have been found to correlate with treatment volumes, and this study’s findings for these outcome measures may reflect the high volume and experience that intense subspecialization and institutional competencies can provide. We recommend that discussions of IA treatment strategies be focused not only on treatment modality choice but also on optimizing patient access to institutions with the resources and support to improve outcomes above those seen in broad national samples. The American Heart Association/American Stroke Association have similarly recommended that the surgical treatment of IAs be performed at high volume centers [44], highlighting the continued need for proper training of young cerebrovascular surgeons to safely undertake these types of operations and deliver superior outcomes to patients.

Limitations

The principal limitations of this report include its retrospective nature, which introduces potential selection bias, and the fact that the operations were performed by a single surgeon at a large volume multidisciplinary center over the course of 23 years, potentially limiting the generalizability of its data. At the same time, since this study describes complications in a large cohort of patients with aneurysms at a wide variety of locations treated during the era of EVT, it is hoped that this work may help address questions regarding the incidence and spectrum of complications as well as the mortality associated with the microsurgical treatment of unruptured IA aneurysms, a technique being used less frequently as EVT improves. This information may become increasingly important to physicians who must decide how to manage patients with unruptured IAs in the future.

Conclusion

Our results in a large series of unruptured IAs demonstrate that careful patient selection by a multidisciplinary team at a high-volume center can yield low complication and mortality rates. This data, from the largest single-center surgical IA treatment series published to date, suggests that tailoring treatment for each unruptured IA can minimize the surgical risk to patients. By providing data regarding the morbidity and mortality rates that can be achieved realistically by applying a multidisciplinary dedicated team approach to the management of unruptured IAs, it is hoped that this work will help physicians better decide between the available treatment options for these complex patients.